2,3-Didocecanoyl-sn-glycero-1-phosphocholine (CAS 127641-86-5)

2,3-Didocecanoyl-sn-glycero-1-phosphocholine, a phospholipid derivative, has emerged as a significant compound in scientific research, particularly in the fields of lipid biochemistry, membrane biophysics, and drug delivery systems. Its mechanism of action primarily stems from its structural resemblance to natural phospholipids found in cell membranes, enabling interactions with lipid bilayers and membrane-associated proteins. In research, 2,3-didocecanoyl-sn-glycero-1-phosphocholine has been extensively studied for its role as a model membrane component in studies of lipid bilayer organization, phase behavior, and membrane dynamics. Its synthetic nature allows for precise control over lipid composition, facilitating investigations into the effects of lipid structure on membrane properties and cellular processes. Furthermore, 2,3-didocecanoyl-sn-glycero-1-phosphocholine serves as a key component in liposomal drug delivery systems, where it acts as a structural scaffold for encapsulating biological agents. Studies have explored its use in targeted drug delivery, controlled release, and enhanced drug stability, offering promising solutions for improving the efficacy and safety of pharmaceutical formulations. Additionally, 2,3-didocecanoyl-sn-glycero-1-phosphocholine derivatives have been investigated for their potential applications in biomaterials and biotechnology, including membrane protein reconstitution, biosensor development, and tissue engineering scaffolds. Overall, 2,3-didocecanoyl-sn-glycero-1-phosphocholine represents a versatile tool in lipid research and biomedical applications, offering insights into membrane structure-function relationships and facilitating the development of innovative drug delivery strategies.